Aimmune skyrockets after entering deal to be acquired by Nestle subsidiary Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Aimmune (AIMT) up 172% after announcing an agreement for Societes des Produits Nestle to acquire the company for $34.50 per share in an all-cash transaction, implying a fully-diluted equity value of $2.6B
- DBV Technologies (DBVT) up 7% after competitor Aimmune was acquired for equity value of $2.6B
- Huntsman (HUN) and Venator Materials (VNTR) up 3% and 19%, respectively, after Huntsman announced that it has entered into a definitive agreement with funds advised by SK Capital Partners, LP to sell approximately 42.5M of the shares it holds in Venator for a cash purchase price of approximately $100M, including a 30-month option for the sale of the remaining approximate 9.5M shares it holds at $2.15 per share
UP AFTER EARNINGS -
- Broadwind (BWEN) up 1%
- Safe-T (SFET) up 3%
DOWN AFTER EARNINGS -
- Regis (RGS) down 1%
- 36Kr Holdings (KRKR) down 2%
ALSO LOWER -
- Lipocine (LPCN) down 17% after announcing that the FDA has informed the company that it needs additional time to complete its review of TLANDO's new drug application
- Walmart (WMT) down 1% after R5 Capital analyst Scott Mushkin downgraded shares to Hold from Buy with a $147 price target following the "significant appreciation" in the stock
- NIO Inc. (NIO) down 7% after the company's 101.775M share secondary offering priced at $17.00
- BigCommerce (BIGC) down 10% after Wall Street analysts rolled out coverage, including Morgan Stanley's Stan Zlotsky, who initiated coverage of the stock with an Underweight rating and $52 price target
Symbols:
AIMT DBVT HUN VNTR BWEN SFET RGS KRKR LPCN WMT NIO BIGC - $130.28 /
-10.14 (-7.22%)
Keywords: Fly Intel, Wall Street, Top Stories, Stocks